The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group

The Collaborative Corneal Transplantation Studies (CCTS) were designed to evaluate the effect of donor-recipient histocompatibility matching and crossmatching on the survival of corneal transplants in high-risk patients. Corneas were allocated to the 419 patients in the double-masked Antigen Matching Study on the basis of serologically defined HLA-A, -B and HLA-DR antigen match. ABO blood group compatibility was determined but not used for recipient selection. The 37 patients in the Crossmatch Study were randomly assigned to receive a cornea from either a positively or negatively crossmatched donor. All patients received topical steroid therapy according to a standard protocol. Matching for HLA-A, -B and HLA-DR antigens had no effect on overall graft survival, the incidence of irreversible rejection, or the incidence of rejection episodes. At 3 years after surgery, the estimated proportion of eyes with graft failure was 41% for the ABO-incompatible group and 31% for the ABO-compatible group (relative risk, 1.43; 95% confidence interval, 1.00 to 2.06). The estimated proportion of eyes with failure from rejection by 3 years was 30% for the ABO-incompatible group and 16% for the ABO-compatible group (relative risk, 1.98; 95% confidence interval, 1.25 to 3.13). The positive group in the Crossmatch Study had fewer graft failures, rejection failures, and rejection episodes than the negative group; however, these differences were not statistically significant. These studies demonstrate that, for high-risk patients who are immunosuppressed by topical steroid therapy and followed up according to the CCTS protocol: (1) neither HLA-A, -B nor HLA-DR antigen matching substantially reduces the likelihood of corneal graft failure; (2) a positive donor-recipient crossmatch does not dramatically increase the risk of corneal graft failure; and (3) ABO blood group matching, which can be achieved with relatively little effort and expense, may be effective in reducing the risk of graft failure.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Deletion of the Chemokine Receptor CCR1 Prolongs Corneal Allograft Survival
Hamrah et al.
IOVS 2007;48:1228-1236.
ABSTRACT | FULL TEXT  

Inflammatory Cytokines Induce Apoptosis of Corneal Endothelium through Nitric Oxide
Sagoo et al.
IOVS 2004;45:3964-3973.
ABSTRACT | FULL TEXT  

Relevance of the Direct Pathway of Sensitization in Corneal Transplantation Is Dictated by the Graft Bed Microenvironment
Huq et al.
J. Immunol. 2004;173:4464-4469.
ABSTRACT | FULL TEXT  

Quantitative evaluation of the corneal endothelium in the mouse after grafting
Plskova et al.
Br. J. Ophthalmol. 2004;88:1209-1216.
ABSTRACT | FULL TEXT  

Role of Tumor Necrosis Factor Receptor Expression in Anterior Chamber-Associated Immune Deviation (ACAID) and Corneal Allograft Survival
Niederkorn et al.
IOVS 2004;45:2674-2681.
ABSTRACT | FULL TEXT  

Fate of MHC-Matched Corneal Allografts in Th1-Deficient Hosts
Hargrave et al.
IOVS 2004;45:1188-1193.
ABSTRACT | FULL TEXT  

Promotion of Corneal Allograft Survival by the Induction of Oxidative Macrophages
Yamada et al.
IOVS 2004;45:448-454.
ABSTRACT | FULL TEXT  

Tissue crossmatch before corneal transplantation
Borderie et al.
Br. J. Ophthalmol. 2004;88:84-87.
ABSTRACT | FULL TEXT  

Rat Corneal Allograft Survival Prolonged by the Superantigen Staphylococcal Enterotoxin B
Pan et al.
IOVS 2003;44:3346-3351.
ABSTRACT | FULL TEXT  

The immune privilege of corneal grafts
Niederkorn
J. Leukoc. Biol. 2003;74:167-171.
ABSTRACT | FULL TEXT  

Survival in High-Risk Eyes of Epithelium-Deprived Orthotopic Corneal Allografts Reconstituted In Vitro with Syngeneic Epithelium
Hori and Streilein
IOVS 2003;44:658-664.
ABSTRACT | FULL TEXT  

High risk corneal grafting
Hill
Br. J. Ophthalmol. 2002;86:945-945.
FULL TEXT  

Identification of a Novel Macrophage Population in the Normal Mouse Corneal Stroma
Brissette-Storkus et al.
IOVS 2002;43:2264-2271.
ABSTRACT | FULL TEXT  

The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin
Halberstadt et al.
Br. J. Ophthalmol. 2002;86:646-652.
ABSTRACT | FULL TEXT  

Effect of Alloantibodies on Corneal Allograft Survival
Hegde et al.
IOVS 2002;43:1012-1018.
ABSTRACT | FULL TEXT  

Long-Term Survival of Corneal Allografts Is Dependent on Intact CD1d-Reactive NKT Cells
Sonoda et al.
J. Immunol. 2002;168:2028-2034.
ABSTRACT | FULL TEXT  

Draining Lymph Nodes of Corneal Transplant Hosts Exhibit Evidence for Donor Major Histocompatibility Complex (MHC) Class II-positive Dendritic Cells Derived from MHC Class II-negative Grafts
Liu et al.
J. Exp. Med. 2002;195:259-268.
ABSTRACT | FULL TEXT  

Influence of HLA-A, HLA-B, and HLA-DR matching on rejection of random corneal grafts using corneal tissue for retrospective DNA HLA typing
Bartels et al.
Br. J. Ophthalmol. 2001;85:1341-1346.
ABSTRACT | FULL TEXT  

Effect of ABO blood group mismatching on corneal epithelial cells: an in vitro study
Chan et al.
Br. J. Ophthalmol. 2001;85:1104-1109.
ABSTRACT | FULL TEXT  

Dynamics of Donor Cell Persistence and Recipient Cell Replacement in Orthotopic Corneal Allografts in Mice
Hori and Streilein
IOVS 2001;42:1820-1828.
ABSTRACT | FULL TEXT  

The Critical Role of Lymph Nodes in Corneal Alloimmunization and Graft Rejection
Yamagami and Dana
IOVS 2001;42:1293-1298.
ABSTRACT | FULL TEXT  

Cytotoxic T Cells Play No Essential Role in Acute Rejection of Orthotopic Corneal Allografts in Mice
Yamada et al.
IOVS 2001;42:386-392.
ABSTRACT | FULL TEXT  

Topical Soluble Tumor Necrosis Factor Receptor Type I Suppresses Ocular Chemokine Gene Expression and Rejection of Allogeneic Corneal Transplants
Qian et al.
Arch Ophthalmol 2000;118:1666-1671.
ABSTRACT | FULL TEXT  

The Role of Cytotoxic T Lymphocytes in Corneal Allograft Rejection
Hegde and Niederkorn
IOVS 2000;41:3341-3347.
ABSTRACT | FULL TEXT  

Gene Delivery to the Corneal Endothelium
GEORGE et al.
Am. J. Respir. Crit. Care Med. 2000;162:S194-200.
ABSTRACT | FULL TEXT  

Corneal transplantation: how successful are we?
WALDOCK and COOK
Br. J. Ophthalmol. 2000;84:813-815.
FULL TEXT  

Effect of Macrophage Depletion on Immune Effector Mechanisms during Corneal Allograft Rejection in Rats
Slegers et al.
IOVS 2000;41:2239-2247.
ABSTRACT | FULL TEXT  

Apoptosis Induced by a Corneal-Endothelium-Derived Cytokine
Liu and Gottsch
IOVS 1999;40:3152-3159.
ABSTRACT | FULL TEXT  

Changes in Cytokine mRNA Levels in Experimental Corneal Allografts after Local Clodronate-Liposome Treatment
Torres et al.
IOVS 1999;40:3194-3201.
ABSTRACT | FULL TEXT  

Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection
Hudde et al.
Br. J. Ophthalmol. 1999;83:1348-1352.
ABSTRACT | FULL TEXT  

Mice with Th2-Biased Immune Systems Accept Orthotopic Corneal Allografts Placed in "High Risk" Eyes
Yamada et al.
J. Immunol. 1999;162:5247-5255.
ABSTRACT | FULL TEXT  

The triple procedure: in the bag placement versus ciliary sulcus placement of the intraocular lens
Borderie et al.
Br. J. Ophthalmol. 1999;83:458-462.
ABSTRACT | FULL TEXT  

Oral immunisation as a strategy for enhancing corneal allograft survival
Ma et al.
Br. J. Ophthalmol. 1997;81:778-784.
ABSTRACT | FULL TEXT  

Conclusions of the corneal transplant follow up study
Vail et al.
Br. J. Ophthalmol. 1997;81:631-636.
ABSTRACT | FULL TEXT  

Corneal transplantation in Britain
Tullo and Dyer
BMJ 1995;310:1347-1348.
FULL TEXT